Brief: Active Biotech Rights Issue To Provide Proceeds Of SEK 76.2 Million
Nov 25 (Reuters) - Active Biotech AB (publ) ACTI.ST :
* REG-ACTIVE BIOTECH ANNOUNCES THE FINAL TERMS OF THE RIGHTS
ISSUE
* RIGHTS ISSUE WILL PROVIDE ACTIVE BIOTECH WITH ISSUE
PROCEEDS OF
APPROXIMATELY SEK 76.2 MILLION, BEFORE TRANSACTION COSTS.
Source text for Eikon: ID:nGNE3zbbNy
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million